COMMUNIQUÉS West-GlobeNewswire
-
Alvotech announces successful closure of FDA inspection of manufacturing facility
29/07/2026 -
Acentra Health Names Srini Surendranath as Senior Vice President of Product and Solutions Management
29/07/2026 -
BPC-157 Introduced by Kylo Peptides for Laboratory Research Purposes
29/07/2026 -
TimelyCare Sets New Standard for Student Safety with URAC Artificial Intelligence in Healthcare Accreditation
29/07/2026 -
Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation
29/07/2026 -
Walmart Canada, ses associés et ses clients recueillent 7,2 millions de dollars pour soutenir les hôpitaux pour enfants partout au Canada
29/07/2026 -
Walmart Canada, Associates and Customers Raise $7.2 Million to Support Children’s Hospitals Across Canada
29/07/2026 -
The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy
29/07/2026 -
Hyperion DeFi Schedules First Quarter Earnings Call for Wednesday, August 12 at 5:00 p.m. ET
29/07/2026 -
BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets
29/07/2026 -
New Research using Clue Data Suggests Menstrual Cycle Timing May Influence Vaccine Side Effects
29/07/2026 -
F6S Ranks Life Backup Plan 55th in Health and Wellness
29/07/2026 -
Shape Therapeutics Receives Research Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance SHP-201, a One-Time Gene Therapy to Treat Parkinson’s Disease
29/07/2026 -
Fortrea Reports Second Quarter 2026 Results
29/07/2026 -
MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF
29/07/2026 -
Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution
29/07/2026 -
Teva Delivers Strong Q2 Results and Raises Outlook for All Three Key Innovative Brands, Reflecting Continued Execution of Its Pivot to Growth Strategy
29/07/2026 -
Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center
29/07/2026 -
VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates
29/07/2026
Pages